Biotricity Announces Continued Margin Improvement Driven by Its Proprietary AI Cloud
Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Biotricity and BioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Express News | Biotricity Shares Are Trading Higher After the Company Announced That It Expects to Reach a Milestone of Being EBITDA Positive
Express News | Biotricity Inc - Expects to Reach Ebitda Positive Before End of Calendar 2024
Express News | Biotricity Inc - Accelerated Timeline to Achieving Ebitda Positive
Biotricity Announces Accelerated Path to EBITDA Positive
Biotricity Adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program
Biotricity | 10-K/A: Annual report (Amendment)
Biotricity Launches HeartSecure: Immediate, At-Home Cardiac Screening Now Available
Earnings Call: Biotricity Reports Growth and Expansion in FY 2024
Biotricity, Inc. (BTCY) Q4 2024 Earnings Call Transcript
Biotricity GAAP EPS of -$0.47, Revenue of $3.2M In-line
Express News | Biotricity Q4 Revenue $3.2M, Up 15.9% YoY, EPS $(0.47)
Express News | Biotricity Q4 Gross Margin 71.5%
Express News | Biotricity Q4 EPS USD -0.47
Express News | Biotricity Q4 Net Income USD -4.4 Million
Biotricity Reports Strong Results With Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses for Fiscal Year 2024, Accelerating the Company's Path to Profitability
Biotricity | 10-K: Annual report
Biotricity to Host Fourth Quarter and Fiscal Year 2024 Financial Results and Business Update Call on June 27